These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 19429166)

  • 1. Characterisation of a novel NR4A2 mutation in Parkinson's disease brain.
    Sleiman PM; Healy DG; Muqit MM; Yang YX; Van Der Brug M; Holton JL; Revesz T; Quinn NP; Bhatia K; Diss JK; Lees AJ; Cookson MR; Latchman DS; Wood NW
    Neurosci Lett; 2009 Jun; 457(2):75-9. PubMed ID: 19429166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in NR4A2 associated with familial Parkinson disease.
    Le WD; Xu P; Jankovic J; Jiang H; Appel SH; Smith RG; Vassilatis DK
    Nat Genet; 2003 Jan; 33(1):85-9. PubMed ID: 12496759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of polymorphisms and reduced expression levels of the NR4A2 gene with Parkinson's disease in a Mexican population.
    Ruiz-Sánchez E; Yescas P; Rodríguez-Violante M; Martínez-Rodríguez N; Díaz-López JN; Ochoa A; Valdes-Rojas SS; Magos-Rodríguez D; Rojas-Castañeda JC; Cervantes-Arriaga A; Canizales-Quinteros S; Rojas P
    J Neurol Sci; 2017 Aug; 379():58-63. PubMed ID: 28716280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear receptor NR4A2 IVS6 +18insG and brain derived neurotrophic factor (BDNF) V66M polymorphisms and risk of Taiwanese Parkinson's disease.
    Chen CM; Chen IC; Chang KH; Chen YC; Lyu RK; Liu YT; Hu FJ; Chao CY; Lee-Chen GJ; Wu YR
    Am J Med Genet B Neuropsychiatr Genet; 2007 Jun; 144B(4):458-62. PubMed ID: 17427185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered NR4A Subfamily Gene Expression Level in Peripheral Blood of Parkinson's and Alzheimer's Disease Patients.
    Montarolo F; Perga S; Martire S; Navone DN; Marchet A; Leotta D; Bertolotto A
    Neurotox Res; 2016 Oct; 30(3):338-44. PubMed ID: 27159982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NR4A2 and schizophrenia: lack of association in a Portuguese/Brazilian study.
    Ruano D; Macedo A; Dourado A; Soares MJ; Valente J; Coelho I; Santos V; Azevedo MH; Goodman A; Hutz MH; Gama C; Lobato MI; Belmonte-de-Abreu P; Palha JA
    Am J Med Genet B Neuropsychiatr Genet; 2004 Jul; 128B(1):41-5. PubMed ID: 15211629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NR4A2 genetic variation in sporadic Parkinson's disease: a genewide approach.
    Healy DG; Abou-Sleiman PM; Ahmadi KR; Gandhi S; Muqit MM; Bhatia KP; Quinn NP; Lees AJ; Holton JL; Revesz T; Wood NW
    Mov Disord; 2006 Nov; 21(11):1960-3. PubMed ID: 16977628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extended mutation analysis and association studies of Nurr1 (NR4A2) in Parkinson disease.
    Hering R; Petrovic S; Mietz EM; Holzmann C; Berg D; Bauer P; Woitalla D; Müller T; Berger K; Krüger R; Riess O
    Neurology; 2004 Apr; 62(7):1231-2. PubMed ID: 15079038
    [No Abstract]   [Full Text] [Related]  

  • 9. Identification and characterization of human NR4A2 polymorphisms in attention deficit hyperactivity disorder.
    Smith KM; Bauer L; Fischer M; Barkley R; Navia BA
    Am J Med Genet B Neuropsychiatr Genet; 2005 Feb; 133B(1):57-63. PubMed ID: 15635701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NR4A2 genetic variation and Parkinson's disease: Evidence from a systematic review and meta-analysis.
    Liu H; Liu H; Li T; Cui J; Fu Y; Ren J; Sun X; Jiang P; Yu S; Li C
    Neurosci Lett; 2017 May; 650():25-32. PubMed ID: 28385514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of previously reported variants in the SCNA (G88C and G209A), NR4A2 (T291D and T245G) and the DJ-1 (T497C) genes in familial Parkinson's disease from the GenePD study.
    Karamohamed S; Golbe LI; Mark MH; Lazzarini AM; Suchowersky O; Labelle N; Guttman M; Currie LJ; Wooten GF; Stacy M; Saint-Hilaire M; Feldman RG; Liu J; Shoemaker CM; Wilk JB; DeStefano AL; Latourelle JC; Xu G; Watts R; Growdon J; Lew M; Waters C; Vieregge P; Pramstaller PP; Klein C; Racette BA; Perlmutter JS; Parsian A; Singer C; Montgomery E; Baker K; Gusella JF; Herbert A; Myers RH
    Mov Disord; 2005 Sep; 20(9):1188-91. PubMed ID: 15966003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Translated mutation in the Nurr1 gene as a cause for Parkinson's disease.
    Grimes DA; Han F; Panisset M; Racacho L; Xiao F; Zou R; Westaff K; Bulman DE
    Mov Disord; 2006 Jul; 21(7):906-9. PubMed ID: 16532445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Point mutations in exon 1 of the NR4A2 gene are not a major cause of familial Parkinson's disease.
    Zimprich A; Asmus F; Leitner P; Castro M; Bereznai B; Homann N; Ott E; Rutgers AW; Wieditz G; Trenkwalder C; Gasser T
    Neurogenetics; 2003 Aug; 4(4):219-20. PubMed ID: 12827450
    [No Abstract]   [Full Text] [Related]  

  • 14. Nurr1 mutational screen in Parkinson's disease.
    Tan EK; Chung H; Chandran VR; Tan C; Shen H; Yew K; Pavanni R; Puvan KA; Wong MC; Teoh ML; Yih Y; Zhao Y
    Mov Disord; 2004 Dec; 19(12):1503-5. PubMed ID: 15390059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic analysis of NR4A2 gene in a large population of Han Chinese patients with Parkinson's disease.
    Liu H; Tao Q; Deng H; Ming M; Ding Y; Xu P; Chen S; Song Z; Le W
    Eur J Neurol; 2013 Mar; 20(3):584-587. PubMed ID: 22827504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Insights into NR4A2(Nurr1): an Emerging Target for Neuroprotective Therapy Against Neuroinflammation and Neuronal Cell Death.
    Jakaria M; Haque ME; Cho DY; Azam S; Kim IS; Choi DK
    Mol Neurobiol; 2019 Aug; 56(8):5799-5814. PubMed ID: 30684217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tyrosine hydroxylase gene regulation in human neuronal progenitor cells does not depend on Nurr1 as in the murine and rat systems.
    Jin H; Romano G; Marshall C; Donaldson AE; Suon S; Iacovitti L
    J Cell Physiol; 2006 Apr; 207(1):49-57. PubMed ID: 16252282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-wide gene expression profiling of the Angelman syndrome mice with Ube3a mutation.
    Low D; Chen KS
    Eur J Hum Genet; 2010 Nov; 18(11):1228-35. PubMed ID: 20571502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclooxygenase-2 inhibitors down-regulate osteopontin and Nr4A2-new therapeutic targets for colorectal cancers.
    Zagani R; Hamzaoui N; Cacheux W; de Reyniès A; Terris B; Chaussade S; Romagnolo B; Perret C; Lamarque D
    Gastroenterology; 2009 Oct; 137(4):1358-66.e1-3. PubMed ID: 19549529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and function of nr4a2, lmx1b, and pitx3 in zebrafish dopaminergic and noradrenergic neuronal development.
    Filippi A; Dürr K; Ryu S; Willaredt M; Holzschuh J; Driever W
    BMC Dev Biol; 2007 Dec; 7():135. PubMed ID: 18053265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.